Matches in Wikidata for { <http://www.wikidata.org/entity/Q64801521> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q64801521 description "clinical trial" @default.
- Q64801521 description "ensayu clínicu" @default.
- Q64801521 description "klinisch onderzoek" @default.
- Q64801521 description "клінічне випробування" @default.
- Q64801521 description "կլինիկական փորձարկում" @default.
- Q64801521 name "A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Subjects With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody" @default.
- Q64801521 type Item @default.
- Q64801521 label "A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Subjects With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody" @default.
- Q64801521 prefLabel "A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Subjects With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody" @default.
- Q64801521 P1050 Q64801521-D722E75A-847D-4F68-A456-77BF3B24F110 @default.
- Q64801521 P1132 Q64801521-ED54F0F8-2C5A-4F78-9755-46654FF1AB5D @default.
- Q64801521 P1476 Q64801521-33AFC1AC-1272-4009-B7D1-867D6C9AF013 @default.
- Q64801521 P17 Q64801521-1011D9C7-30BE-4093-BB1A-6E75C277526C @default.
- Q64801521 P17 Q64801521-16DADA1E-1B7F-477E-A5CC-CF92CCD33B7B @default.
- Q64801521 P17 Q64801521-4B22E8DE-597A-42D6-9DB8-CB5F8E99CFA2 @default.
- Q64801521 P17 Q64801521-8AFCE3DF-8AB1-45C9-8F8C-17ADD2110666 @default.
- Q64801521 P17 Q64801521-A9499961-70FA-41C9-AE5C-24B2F6E99560 @default.
- Q64801521 P17 Q64801521-B3C5675A-CFB2-4ADE-BA5B-6C99460B5A78 @default.
- Q64801521 P17 Q64801521-E719EE40-81EB-487F-BF23-E358583CECEE @default.
- Q64801521 P17 Q64801521-E9DE13FA-60B5-4F15-B637-36329E9792C4 @default.
- Q64801521 P2899 Q64801521-EEE4E428-991F-4BFF-A082-20C3ABDD3AC9 @default.
- Q64801521 P3098 Q64801521-C7A99C1A-78AC-4679-9EB3-D4ADD768A981 @default.
- Q64801521 P31 Q64801521-BA914CCF-E54A-48AE-ACEF-3FBD2161F81F @default.
- Q64801521 P580 Q64801521-C7319B54-5451-4B5B-8065-9C38C60373E6 @default.
- Q64801521 P582 Q64801521-28610B57-FDD0-4B8D-B30F-435022F0BDA3 @default.
- Q64801521 P6099 Q64801521-191C3417-E72B-40D7-86DE-72B0ED58FCD6 @default.
- Q64801521 P6153 Q64801521-94CFFBCA-BF5F-43B1-815C-7E0112EAABF5 @default.
- Q64801521 P8363 Q64801521-693A882F-E383-4E14-8A6E-EC84D7052425 @default.
- Q64801521 P859 Q64801521-C613C0F2-B2EB-4E3E-8382-A9C9045E4953 @default.
- Q64801521 P1050 Q467635 @default.
- Q64801521 P1132 "+155" @default.
- Q64801521 P1476 "A Phase II, Open Label, Randomized, Two-Arm Study to Investigate the Efficacy and Safety of Two Doses of the Antibody Drug Conjugate GSK2857916 in Participants With Multiple Myeloma Who Had 3 or More Prior Lines of Treatment, Are Refractory to a Proteasome Inhibitor and an Immunomodulatory Agent and Have Failed an Anti-CD38 Antibody (DREAMM 2)" @default.
- Q64801521 P17 Q142 @default.
- Q64801521 P17 Q145 @default.
- Q64801521 P17 Q16 @default.
- Q64801521 P17 Q183 @default.
- Q64801521 P17 Q29 @default.
- Q64801521 P17 Q30 @default.
- Q64801521 P17 Q38 @default.
- Q64801521 P17 Q408 @default.
- Q64801521 P2899 "+18" @default.
- Q64801521 P3098 "NCT03525678" @default.
- Q64801521 P31 Q30612 @default.
- Q64801521 P580 "2018-06-18T00:00:00Z" @default.
- Q64801521 P582 "2019-06-21T00:00:00Z" @default.
- Q64801521 P6099 Q42824440 @default.
- Q64801521 P6153 Q212322 @default.
- Q64801521 P8363 Q78089383 @default.
- Q64801521 P859 Q212322 @default.